Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores

PLoS ONE - United States
doi 10.1371/journal.pone.0081048
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Myelodysplastic Syndromes: Histopathology as Prognostic Factor

Revista Brasileira de Hematologia e Hemoterapia
2001English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2013English

Prognostic Role of TET2 Deficiency in Myelodysplastic Syndromes: A Meta-Analysis

Oncotarget
Oncology
2017English

ABC of Clinical Haematology: The Myelodysplastic Syndromes

BMJ
1997English

U2AF1 Mutation Variants in Myelodysplastic Syndromes and Their Clinical Correlates

American Journal of Hematology
Hematology
2018English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy